ACTIMMUNE Trademark

Trademark Overview

On Wednesday, April 26, 1989, a trademark application was filed for ACTIMMUNE with the United States Patent and Trademark Office. The USPTO has given the ACTIMMUNE trademark a serial number of 73796028. The federal status of this trademark filing is REGISTERED AND RENEWED as of Wednesday, August 19, 2020. This trademark is owned by GENENTECH, INC.. The ACTIMMUNE trademark is filed in the Pharmaceutical Products category with the following description:

PHARMACEUTICAL PREPARATIONS, NAMELY, BIOLOGICALS RESPONSE MODIFIERS AND ANTIFIBROTIC AGENTS, PRIMARILY FOR USE AS (1) ANTI-INFECTIVE AGENTS FOR THE PREVENTION AND OR TREATMENT OF BACTERIAL, VIRAL OR FUNGAL INFECTIONS; (2) A TREATMENT FOR ABNORMAL PROLIFERATION OF FIBROBLASTIC CELLS SUCH AS KHELOIDS, BURNS OR SCLERODERMA; [ (3) AN ANTIPROLIFERATIVE AGENT FOR THE TREATMENT OF CANCER; (4) A TREATMENT FOR ALLERGIC DISEASES SUCH AS ATOPIC DERMITITIS, ASTHMA, AND ALLERGIC RHINITIS; AND (5) A TREATMENT FOR INFLAMATORY DISEASES SUCH AS CHRON'S DISEASE ]
actimmune

General Information

Serial Number73796028
Word MarkACTIMMUNE
Filing DateWednesday, April 26, 1989
Status800 - REGISTERED AND RENEWED
Status DateWednesday, August 19, 2020
Registration Number1617288
Registration DateTuesday, October 16, 1990
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, July 24, 1990

Trademark Statements

Goods and ServicesPHARMACEUTICAL PREPARATIONS, NAMELY, BIOLOGICALS RESPONSE MODIFIERS AND ANTIFIBROTIC AGENTS, PRIMARILY FOR USE AS (1) ANTI-INFECTIVE AGENTS FOR THE PREVENTION AND OR TREATMENT OF BACTERIAL, VIRAL OR FUNGAL INFECTIONS; (2) A TREATMENT FOR ABNORMAL PROLIFERATION OF FIBROBLASTIC CELLS SUCH AS KHELOIDS, BURNS OR SCLERODERMA; [ (3) AN ANTIPROLIFERATIVE AGENT FOR THE TREATMENT OF CANCER; (4) A TREATMENT FOR ALLERGIC DISEASES SUCH AS ATOPIC DERMITITIS, ASTHMA, AND ALLERGIC RHINITIS; AND (5) A TREATMENT FOR INFLAMATORY DISEASES SUCH AS CHRON'S DISEASE ]
Pseudo MarkACT IMMUNE; ACTIVE IMMUNE

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, May 15, 1989
Primary Code005
First Use Anywhere DateThursday, March 2, 1989
First Use In Commerce DateThursday, March 2, 1989

Trademark Owner History

Party NameGENENTECH, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSOUTH SAN FRANCISCO, CA 940804990
Party NameGENENTECH, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSOUTH SAN FRANCISCO, CA 94080
Party NameGENENTECH, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSOUTH SAN FRANCISCO, CA 94080

Trademark Events

Event DateEvent Description
Wednesday, April 19, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, April 19, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, April 19, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, April 19, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, August 25, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, August 25, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, August 25, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, August 25, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, April 19, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, April 19, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, April 19, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, April 19, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, April 19, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, August 19, 2020NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Wednesday, August 19, 2020REGISTERED AND RENEWED (THIRD RENEWAL - 10 YRS)
Wednesday, August 19, 2020REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Wednesday, August 19, 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, July 2, 2020TEAS SECTION 8 & 9 RECEIVED
Wednesday, October 16, 2019COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Thursday, March 17, 2011REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
Thursday, March 17, 2011REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Wednesday, March 16, 2011CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, March 15, 2011TEAS SECTION 8 & 9 RECEIVED
Tuesday, December 16, 2008CASE FILE IN TICRS
Friday, March 23, 2001REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Friday, March 23, 2001REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Friday, March 16, 2001POST REGISTRATION ACTION MAILED - SEC. 8 & 9
Monday, October 16, 2000REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
Thursday, November 7, 1996REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, September 17, 1996REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Tuesday, October 16, 1990REGISTERED-PRINCIPAL REGISTER
Tuesday, July 24, 1990PUBLISHED FOR OPPOSITION
Saturday, June 23, 1990NOTICE OF PUBLICATION
Monday, April 9, 1990APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, March 2, 1990ASSIGNED TO EXAMINER
Friday, February 9, 1990CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, August 5, 1989NON-FINAL ACTION MAILED
Thursday, June 29, 1989ASSIGNED TO EXAMINER

Related Keywords

actimmune treatment such allergic agents diseases antiproliferative agent scleroderma burns disease